Navigation Links
Victhom announces the completion of the second phase of the apnea therapy development
Date:1/12/2009

QUEBEC, Jan. 12 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc., "Victhom" (TSX: VHB), announced today the filing of an additional patent for the detection and treatment of sleep apnea and has also disclosed the preliminary results from its preclinical studies.

The Company has recently filed a new patent application relating to a method and device for the detection, identification and treatment of sleep apnea/hypopnea using its neuromodulation platform. Late in 2007, the Company filed a patent application on detection of obstructive apnea from sensory signals in vagal nerve. The continued research has revealed that in fact, sensory signals in various nerves innervating the larynx and the breathing airway can provide a good source for the detection of respiration rate and onset and the duration of any form of apneic event. "The new findings are filed in a comprehensive patent application that captures our unique approach to detection and treatment of respiratory disorders", said Mr. Kameli, Chief Operating Officer of the Neurobionix division.

Over the course of 2008, the Company has validated its findings in various preclinical research studies. Initial preclinical results show that the technology can successfully detect onset, duration and termination of any form of respiratory distress such as hypopnea, obstructive apnea, and central apnea. "The detection of apnea has always been a challenge", stated Mr. Kameli. "Many companies have tried various technologies with various degrees of success. The issue seems to be that artificial sensors that need to be placed in the airway of patients are neither accurate nor patient-friendly. Patient compliance and ease of use seems to be an issue", continued Mr. Kameli. He further stated, "Victhom has been able, in preclinical studies, to decode what the lungs and the airway passages are reporting to the brain to identify when the subject is in distress and is in need of help. No other form of sensing c
'/>"/>

SOURCE VICTHOM HUMAN BIONICS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Victhom Announces Launch of Enhanced Company Website
2. Victhom to Participate in the OneMedPlace Finance Forum
3. Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
4. The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates
5. Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium
6. Abbott Announces Earnings Guidance for 2009
7. Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
8. Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase
9. SemBioSys announces senior management changes
10. Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C
11. Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Carahsoft and CDS Federal Services have ... at 2pm EST (11am PST), “Natural Language Processing: Converting ... how technology can turn raw, heterogeneous data into actionable ... The online webinar will last approximately one hour. , ...
(Date:1/14/2014)... 14, 2014  3D Communications, a leading provider of strategic communications services ... media events in the United States and ... Virginia Cox , JD, is returning to the firm,s ... re-joins 3D after more than two years of service as Associate ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, ... is an emerging biomedical company acquiring, developing, manufacturing, and ... , Free report download: http://equitiesiq.com/reports/alliqua/ , In ... team and Board, which launched the company’s new strategy ...
(Date:1/14/2014)... and BETHESDA, Md. , Jan. 14, ... with two institutes from the National Institutes of Health ... bringing safer, more effective treatments to patients on a ... for Advancing Translational Sciences (NCATS) and the National Eye ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
... New Haven, Conn. A study by Yale researchers offers ... among individuals suggesting that it is due less to ... that cause extended segments of the human genome to be ... focus for identifying genetic differences has traditionally been on point ...
... As the sizes of sensor networks and mobile devices ... a growing need for suitable power sources. Because even ... in nanoscale devices, scientists are exploring nanosize systems that ... the University of Illinois have shown that a single ...
... ST. LOUIS, Sept. 27 Sigma-Aldrich (Nasdaq:,SIAL) is ... been named the,Vice President of R&D for the ... this role, he will help expand Sigma-Aldrich,s,leadership position ... life science researchers. Sullivan has been involved with ...
Cached Biology Technology:Individual differences caused by shuffled chunks of DNA in the human genome 2Individual differences caused by shuffled chunks of DNA in the human genome 3Nanowire generates power by harvesting energy from the environment 2Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech 2
(Date:7/9/2014)... in which animals can be found, concern mounts over ... increased range for a host mean new territory for ... team of UC Santa Barbara scientists, including parasitologists Ryan ... the Journal of Biogeography , Hechinger, Kuris and ... happen: Hosts may actually lose their parasites when the ...
(Date:7/9/2014)... Tampa, Fla. (July 9, 2014) Emerging fungal ... any other parasitic group, causing population declines of ... from the University of South Florida published in ... amphibians can acquire behavioral or immunological resistance to ... population declines. , "Acquired resistance is important ...
(Date:7/9/2014)... critically ill children with traumatic injuries have identified ... likely to develop a hospital-acquired infection. The study, ... published online in June in the journal ... that could lead to the clinical implementation of ... or reverse immune system damage following critical illness ...
Breaking Biology News(10 mins):Not at home on the range 2Not at home on the range 3Not at home on the range 4USF study: Amphibians can acquire resistance to deadly fungus 2Immune function predicts infection risk among child trauma patients 2Immune function predicts infection risk among child trauma patients 3
... 2010) In the Opening Session of the American ... AAPS President Danny D. Shen, Ph.D., presented the following ... pharmaceutical sciences: Excellence in Ligand-Binding Assay Award ... ANP Technologies, Inc.: Ray Yin; Yli Vallejo; Jing Pan, ...
... what impatiens to plant in your yard, a recent study ... Cajun Carmine, that is if you want fewer insects in ... impatiens attract more thrips than others was one of the ... off by flowers are actually complex compounds known as plant ...
... has been constructed by researchers at the Virginia ... gamma-proteobacteria, a large group of medically and scientifically ... and other disease-causing organisms.* By building powerful phylogenetic ... and differences between the make-up of many different ...
Cached Biology News:AAPS announces 2010 NBC award winners 2When plants attract bugs, it may be their own fault 2When plants attract bugs, it may be their own fault 3New 'Tree of Life' established for one of the largest groups of bacteria 2New 'Tree of Life' established for one of the largest groups of bacteria 3
... Combination inline heater plus multi-channel focal ... drug wash-out with a high-flow bath line ... solutions through the Perfusion Pencil.® Steady 37°C ... the bath line and tip. ...
Mouse monoclonal [ICRF 44] to Integrin alpha M...
Mouse Amphiregulin MAb (Clone 206220)...
Request Info...
Biology Products: